Medication info
Cabalin CR Extended-Release Tablet 300 mg (Pregabalin)

Cabalin CR Extended-Release Tablet 300 mg (Pregabalin)

Prescription medicationTablet
Ingredient · strength
Pregabalin›188.5mg / 1 tablet
Manufacturer / importer
GL Pharmtech Co., Ltd.
Appearance
White to pale yellow oblong film-coated extended-release tablets
Packaging
30 tablets (6 tablets/PTP x 5)
Approval status
Active

MFDS item code 201900144 · Approved 2019.01.11 · Insurance code 624200020

Summary

Main use
Treatment of peripheral neuropathic pain in adults
Who uses it
Adults · Children
Adult dosage
1. This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. Adults: A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Discontinuation: Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. 2. Patients with renal impairment The safety and efficacy of this medicine have not been established in patients with renal impairment. 3. Patients with hepatic impairment The safety and efficacy of this medicine have not been established in patients with hepatic impairment. 5. Older adults (aged 65 years or older) The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
Children's dosage
Pediatric and adolescent patients under 19 years of age: The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Ingredients

Manufacturer
GL Pharmtech Co., Ltd.

Efficacy & effects

Treatment of peripheral neuropathic pain in adults

  • Peripheral neuropathic pain
View approved original text

This medication is used to relieve pain caused by peripheral neuropathy in adults. Peripheral neuropathic pain often accompanies abnormal sensations due to nerve damage, which can lead to discomfort in daily life. This medication helps to modulate pain signals, reducing the patient's pain and improving the quality of life.

Dosage and Administration

Adult dosage

1. This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. Adults: A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Discontinuation: Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. 2. Patients with renal impairment The safety and efficacy of this medicine have not been established in patients with renal impairment. 3. Patients with hepatic impairment The safety and efficacy of this medicine have not been established in patients with hepatic impairment. 5. Older adults (aged 65 years or older) The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.

Children's dosage

Pediatric and adolescent patients under 19 years of age: The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Precautions

This medication acts on the central nervous system and may cause mental health issues such as depression or suicidal thoughts, so careful observation for such symptoms is necessary during treatment. Patients with hypersensitivity or allergy to any components of this medication should avoid it. Diabetic patients may experience weight gain from this medication, which can affect blood sugar control, thus requiring adjustments in their antidiabetic medication dosages. If symptoms of angioedema such as swelling around the face or mouth occur, the use of this medication should be stopped immediately. Elderly patients may experience side effects such as dizziness, drowsiness, or loss of consciousness more commonly, hence caution is required at the start of treatment. Blurry vision or changes in vision may occur, and these symptoms may improve upon discontinuation of the medication. Abruptly stopping this medication may lead to withdrawal symptoms such as insomnia, headache, or anxiety, hence dosage should be adjusted according to the physician's directions. There is a risk of drug abuse, so patients with a history of substance abuse should be particularly cautious and monitored for signs of abuse. Patients with reduced kidney function may need dosage adjustments for this medication. Patients with severe heart disease should exercise caution when using this medication. When taken in conjunction with opioid analgesics, there is an increased risk of central nervous system depression, potentially leading to serious side effects such as respiratory distress, so caution is warranted. In early pregnancy, there is a risk of fetal malformations, making it crucial for women who are pregnant or planning to become pregnant to consult a physician and employ effective contraceptive methods. During breastfeeding, this medication can be transmitted through breast milk and may affect infants, thus breastfeeding should be discussed with a physician. Dizziness and drowsiness may occur during treatment, hence it is advisable to avoid dangerous activities such as driving or operating machinery until familiar with the medication. In cases of overdose, symptoms such as confusion, drowsiness, or seizures may appear, necessitating immediate medical attention.

Side effects

  • Suicidal thoughts
  • suicidal behavior
  • depression
  • abnormal changes in mood and behavior
  • angioedema
  • facial swelling
  • perioral edema
  • upper airway edema
  • dizziness
  • drowsiness
Show 107 more
  • loss of consciousness
  • confusion
  • mental disorders
  • blurred vision
  • changes in vision
  • insomnia
  • headache
  • nausea
  • diarrhea
  • influenza-like syndrome
  • restlessness
  • suicidal thoughts
  • pain
  • seizures
  • sweating
  • weight gain
  • constipation
  • dyspepsia
  • nausea
  • dry mouth
  • vomiting
  • peripheral edema
  • bradycardia
  • palpitations
  • pruritus
  • arthralgia
  • hypoglycemia
  • rhinitis
  • hypertension
  • angioedema
  • allergic reactions
  • headache
  • loss of consciousness
  • mental disorders
  • keratitis
  • congestive heart failure
  • pulmonary edema
  • nausea
  • diarrhea
  • tongue swelling
  • facial swelling
  • itching
  • toxic epidermal necrolysis
  • urinary retention
  • gynecomastia
  • lethargy
  • fatigue
  • weakness
  • gait abnormalities
  • decreased libido
  • sleep disorders
  • ataxia
  • speech impairment
  • sensory disturbances
  • memory impairment
  • attention deficit
  • constipation
  • gastrointestinal disorders
  • bloody stools
  • increased BUN
  • incontinence
  • difficulty urinating
  • erectile dysfunction
  • hypoglycemia
  • increased appetite
  • diplopia
  • blurred vision
  • tinnitus
  • skin disorders
  • increased serum creatinine
  • tremors
  • worsened seizures
  • delirium
  • paralysis
  • slowed motor function
  • Guillain-Barré syndrome
  • discomfort in the head
  • weakness
  • heat sensation
  • deep vein thrombosis
  • pneumonia
  • thalamic infarction
  • osteoarthritis
  • synovial cyst
  • anemia
  • oral paresthesia
  • contusions
  • diabetic retinopathy
  • atrial fibrillation
  • sweating
  • thyroid mass
  • thyroid mass
  • spinal canal stenosis
  • musculoskeletal discomfort
  • limb discomfort
  • abdominal pain
  • upper abdominal pain
  • eyelid swelling
  • cataracts
  • increased blood alkaline phosphatase
  • ear disorders
  • mood disorders
  • drowsiness
  • confused state
  • depression
  • agitation
  • restlessness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy over time.

Appearance and packaging

Appearance

White to pale yellow oblong film-coated extended-release tablets

Package unit

30 tablets (6 tablets/PTP x 5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.